About Trefoil Therapeutics
Trefoil Therapeutics is a private company based in El Cajon, California. It has reported $33,299,043 raised in four offerings on Form D since December 2016. Its chief executive is Jonathan Mow.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 23, 2025 | May 7, 2025 | $4,559,996of $5.0M target | 16 | $284K | EquityRule 506(b) | Form D ↗ |
| Mar 8, 2022 | Mar 22, 2022 | $11,970,548of $12.0M target | 14 | $855K | EquityRule 506(b) | Form D ↗ |
| Jul 3, 2019 | Jul 17, 2019amended Aug 5, 2019 | $12,604,500of $28.0M target | 13 | $969K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 1, 2016 | Dec 8, 2016 | $4,163,999of $5.1M target | 14 | $297K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $33,299,043 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Trefoil Therapeutics's Form D filed May 7, 2025.
CS
Christy Shaffer
Director
SR
Stella Robertson
Director
JM
Jonathan Mow
Chief Executive Officer
BM
Ben McGraw
Director
JF
John Fucci
Director
KS
Kseniya Simpson
Director
Earlier filings also listed Schalon Newton (executive officer, last listed Mar 2022), Derek Yoon (director, last listed Mar 2022), David Eveleth (ceo and director, last listed Mar 2022) and Ralph Bradshaw (director, last listed Dec 2016).